Abecab 5/20mg Tablet 1 Strip

✔️ Therapeutic Class

Combination antihypertensive agents (Calcium Channel Blocker + ARB).

✔️ Dosage & Administration

Patients already taking Amlodipine and Olmesartan separately can switch to Abecab at equivalent doses. The combination may be adjusted by increasing the dose of either or both components as needed.

Initial dose: 5/20 mg once daily, which can be increased over 1–2 weeks to a maximum of 10/40 mg once daily.

Elderly patients (≥75 years): Since Amlodipine clearance is reduced, a starting dose of 2.5 mg is advisable, but the combination product does not allow for this lower dose. Therefore, starting therapy with Abecab is not advised in this age group.

Pediatrics: Safety and efficacy are not established.

Geriatrics: No notable differences in safety or efficacy compared to younger patients.

Renal impairment: No dedicated studies available.

Hepatic impairment: Not recommended as initial therapy.

✔️ Side Effects

• Peripheral swelling
• Headache
• Facial flushing
• Dizziness

✔️ Drug Interactions

Nonsteroidal anti-inflammatory drugs (NSAIDs), including COX-2 inhibitors, may reduce the antihypertensive effect of Olmesartan. Close monitoring of blood pressure, kidney function, and electrolytes is recommended when used in combination with NSAIDs or other agents that affect the renin-angiotensin system (RAS).

✔️ Contraindications

Concomitant use with Aliskiren is contraindicated in diabetic patients due to the risk of renal impairment, hypotension, and hyperkalemia.

✔️ Use During Pregnancy & Lactation

Pregnancy Category D: Not recommended during the second or third trimester due to the risk of fetal harm or death. Discontinue immediately if pregnancy is detected.

Lactation: It is unclear whether the drug is secreted in human milk. A risk-benefit assessment should guide the decision to continue the drug or breastfeeding.

✔️ Precautions & Warnings

Use cautiously in the following cases:

• Patients with volume or salt depletion may experience symptomatic hypotension.
• Patients with severe aortic stenosis may have exaggerated responses due to vasodilation.
• Patients with severe coronary artery disease may experience worsening angina or an acute myocardial infarction when starting or increasing doses.

✔️ Storage:

Store at temperatures not exceeding 30°C. Protect from light and moisture. Keep out of children's reach.